Broadcast Date: Wednesday, October 23, 2024
from 12:00 pm to 1:00 pm (ET)

Overview:

Navigating the balance between protecting innovation and ensuring access to affordable medications is crucial.

Join Jason A. Lief of Windels Marx and William C. Baton of Saul Ewing LLP in this CLE webcast as they delve into the intricacies of the Hatch-Waxman Act and its profound impact on the pharmaceutical industry. Designed for legal professionals, pharmaceutical executives, and anyone navigating the complex landscape of drug development, this webinar will provide invaluable insights into leveraging Hatch-Waxman strategies to safeguard intellectual property while ensuring broader access to life-saving medications.

Key Topics to be Discussed:

  • Pleading Standards in a Hatch-Waxman Case
    • How are Courts Applying Iqbal-Twombly to Hatch-Waxman Cases
  • Interplay of Invalidity in PTAB IPR Proceedings and the Federal Courts
    • Schrodinger’s Patents: Can a Patent be Valid and Invalid at the Same Time?
  • Skinny Label Updates
    • What Has Happened Since Glaxo v. Teva: Amarin v. Hikma in the Federal Circuit
  • New Jersey’s Contentions Rules and How They Differ in Hatch-Waxman Cases
  • Disputes Regarding Expert Reports and Contentions in New Jersey Hatch-Waxman Cases
  • Early Limiting of Patent Claims in New Jersey Hatch-Waxman Cases?

Credit:

Course Level:

Intermediate

 

Advance Preparation:

Print and review course materials

 

Method of Presentation:

On-Demand Webcast

 

Prerequisite:

General knowledge of the Hatch-Waxman Act

 

Course Code:

1411245

 

Total Credits:

1.00

 

CLE Credit:

 

CA CLE 1.00 General - Approved Until: 10/23/2026

PA CLE 1.00 General - Approved Until: 10/23/2026

VT CLE 1:00 General - Approved Until: 12/31/2025

NJ CLE 1:00 General - Credits through Reciprocity

NY CLE 1:00 Areas of Professional Practice - Credits through Reciprocity

AR CLE 1:00 General - Credits through Reciprocity

CT CLE 1:00 General - Credits through Reciprocity

NH CLE 1.00 General – Meets the requirements of NH Supreme Court Rule 53

MO CLE 1.00 General - Approved Until: 10/23/2024

GA CLE 1.00 General - Approved Until: 12/31/2024

TN CLE 1.00 General - Approved Until: 10/23/2025

WI CLE 1.00 General - Approved Until: 12/31/2025

MS CLE 1.00 General - Approved Until: 10/23/2025

 

Self-Apply:

AL, CO, DE, FL, ID, IN, IO, KS, KY, LA, NC, ME, MN, MT, NE, NV, NM, ND, OH, OK, OR, SC, TX, UT, VA, WA, WV, WY

 

If you’d like us to apply for CLE, you may opt to pay the CLE processing fee here.

 

No MCLE Requirements:

DC, MD, MA, MI, SD

 

Not Eligible for CLE:

AK, AZ, HA, IL

Speaker Panel:

Jason A. Lief, Partner
Windels Marx

Jason Lief is a premier patent trial lawyer with 25 years of experience. He has litigated and tried dozens of major patent and other intellectual property cases on behalf of some of the world’s most innovative and dynamic companies, often involving billion dollar products. Applying his legal and scientific training, Jason has established a reputation for winning outcomes and courtroom excellence.

William C. Baton, Partner
Saul Ewing LLP

William Baton is a partner at Saul Ewing LLP. His practice includes high-profile representations in Hatch-Waxman, biologics, and other types of patent litigation, trade secrets litigation, and antitrust litigation. He is Co-Chair of Saul Ewing’s Intellectual Property Group and is co-leader of the firm’s Trade Secrets Specialty Group. Mr. Baton has been recognized by Chambers USA for his expertise in intellectual property litigation, is a Master of the John C. Lifland Intellectual Property Inn of Court, and serves as a Trustee of the Association of the Federal Bar of New Jersey.

Agenda:

Segment 1:

Jason A. Lief, Partner

Windels Marx

  1. Pleading Standards in a Hatch-Waxman Case
    • How are Courts Applying Iqbal-Twombly to Hatch-Waxman Cases
  2. Interplay of Invalidity in PTAB IPR Proceedings and the Federal Courts
    • Schrodinger’s Patents: Can a Patent be Valid and Invalid at the Same Time?
  3. Skinny Label Updates
    • What Has Happened Since Glaxo v. Teva: Amarin v. Hikma in the Federal Circuit

Segment 2:

William C. Baton, Partner 

Saul Ewing LLP

  • New Jersey’s Contentions Rules and How They Differ in Hatch-Waxman Cases
  • Disputes Regarding Expert Reports and Contentions in New Jersey Hatch-Waxman Cases
  • Early Limiting of Patent Claims in New Jersey Hatch-Waxman Cases?

Date & Time:

Wednesday, October 23, 2024

12:00 pm to 1:00 pm (ET)

Who Should Attend:

  • Intellectual Property Lawyers/Consultants
  • Patent Lawyers
  • Pharmaceutical Industry Lawyers and Executives
  • Regulatory Compliance Officers
  • Healthcare Providers

SPEAKERS

Jason A. LiefPartner
Windels Marx
William C. BatonPartner
Saul Ewing LLP

SUBSCRIPTION PACKAGES

ALL-ACCESS PASS

View Details

CLE LAW MONTHLY

View Details

CPE FINANCE MONTHLY

View Details

Join Over 160,000 Professionals Empowering Their Careers

Learn anywhere from over 3000+ live and recorded CLE, CPE & Technology Webcasts.